Legend Biotech Corporation

06/05/2025 | Press release | Distributed by Public on 06/05/2025 06:22

Legend Biotech Appoints Peter Salovey, Ph.D., as Lead Independent Director (Form 6-K)

Legend Biotech Appoints Peter Salovey, Ph.D., as Lead Independent Director

On June 5, 2025, Legend Biotech Corporation (the "Company") announced the appointment of Peter Salovey, Ph.D., President Emeritus of Yale University, as Lead Independent Director, effective June 5, 2025.

Dr. Salovey has served as an independent director of the Company's Board of Directors since August 2024. He brings deep leadership experience and a track record of guiding organizations with integrity and vision through periods of strategic growth. In his new role, Dr. Salovey will serve as a key liaison among the Board of Directors, management, and shareholders.

This report on Form 6-K is hereby incorporated herein by reference in the registration statements of the Company on Form F-3 (Nos. 333-278050, 333-272222 and 333-257625) and Form S-8 (No. 333-239478 and 333-283217), to the extent not superseded by documents or reports subsequently filed.

Legend Biotech Corporation published this content on June 05, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 05, 2025 at 12:22 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io